Literature DB >> 15314185

NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity.

Shuichi Fujioka1, Jiangong Niu, Christian Schmidt, Guido M Sclabas, Bailu Peng, Tadashi Uwagawa, Zhongkui Li, Douglas B Evans, James L Abbruzzese, Paul J Chiao.   

Abstract

Nuclear factor kappaB (NF-kappaB) and activator protein 1 (AP-1) transcription factors regulate many important biological and pathological processes. Activation of NF-kappaB is regulated by the inducible phosphorylation of NF-kappaB inhibitor IkappaB by IkappaB kinase. In contrast, Fos, a key component of AP-1, is primarily transcriptionally regulated by serum responsive factors (SRFs) and ternary complex factors (TCFs). Despite these different regulatory mechanisms, there is an intriguing possibility that NF-kappaB and AP-1 may modulate each other, thus expanding the scope of these two rapidly inducible transcription factors. To determine whether NF-kappaB activity is involved in the regulation of fos expression in response to various stimuli, we analyzed activity of AP-1 and expression of fos, fosB, fra-1, fra-2, jun, junB, and junD, as well as AP-1 downstream target gene VEGF, using MDAPanc-28 and MDAPanc-28/IkappaBalphaM pancreatic tumor cells and wild-type, IKK1-/-, and IKK2-/- murine embryonic fibroblast cells. Our results show that elk-1, a member of TCFs, is one of the NF-kappaB downstream target genes. Inhibition of NF-kappaB activity greatly decreased expression of elk-1. Consequently, the reduced level of activated Elk-1 protein by extracellular signal-regulated kinase impeded constitutive, serum-, and superoxide-inducible c-fos expression. Thus, our study revealed a distinct and essential role of NF-kappaB in participating in the regulation of elk-1, c-fos, and VEGF expression. Copyright 2004 American Society for Microbiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15314185      PMCID: PMC507000          DOI: 10.1128/MCB.24.17.7806-7819.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  86 in total

1.  Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activation.

Authors:  Christian Schmidt; Bailu Peng; Zhongkui Li; Guido M Sclabas; Shuichi Fujioka; Jiangong Niu; Marc Schmidt-Supprian; Douglas B Evans; James L Abbruzzese; Paul J Chiao
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

2.  A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK).

Authors:  Ken Yanagisawa; Kenji Tago; Morisada Hayakawa; Motomichi Ohki; Hiroyuki Iwahana; Shin-Ichi Tominaga
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

3.  TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB.

Authors:  Soo Woong Lee; Sang-In Han; Hong-Hee Kim; Zang Hee Lee
Journal:  J Biochem Mol Biol       Date:  2002-07-31

4.  Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis.

Authors:  Shuichi Fujioka; Guido M Sclabas; Christian Schmidt; Jiangong Niu; Wayne A Frederick; Qiang G Dong; James L Abbruzzese; Douglas B Evans; Cheryl Baker; Paul J Chiao
Journal:  Oncogene       Date:  2003-03-06       Impact factor: 9.867

5.  VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2.

Authors:  Serafim Kiriakidis; Evangelos Andreakos; Claudia Monaco; Brian Foxwell; Marc Feldmann; Ewa Paleolog
Journal:  J Cell Sci       Date:  2003-02-15       Impact factor: 5.285

6.  Function of nuclear factor kappaB in pancreatic cancer metastasis.

Authors:  Shuichi Fujioka; Guido M Sclabas; Christian Schmidt; Wayne A Frederick; Qiang G Dong; James L Abbruzzese; Douglas B Evans; Cheryl Baker; Paul J Chiao
Journal:  Clin Cancer Res       Date:  2003-01       Impact factor: 12.531

7.  POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis.

Authors:  Zhiheng Xu; Nickolay V Kukekov; Lloyd A Greene
Journal:  EMBO J       Date:  2003-01-15       Impact factor: 11.598

Review 8.  NF-kappaB regulation in the immune system.

Authors:  Qiutang Li; Inder M Verma
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

9.  Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2.

Authors:  Salvatore Papa; Francesca Zazzeroni; Concetta Bubici; Shanthi Jayawardena; Kellean Alvarez; Shuji Matsuda; Dung U Nguyen; Can G Pham; Andreas H Nelsbach; Tiziana Melis; Enrico De Smaele; Wei-Jen Tang; Luciano D'Adamio; Guido Franzoso
Journal:  Nat Cell Biol       Date:  2004-01-25       Impact factor: 28.824

10.  A JNK-dependent pathway is required for TNFalpha-induced apoptosis.

Authors:  Yibin Deng; Xiaoyang Ren; Lin Yang; Yahong Lin; Xiangwei Wu
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

View more
  148 in total

1.  Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction.

Authors:  Jennifer Cheng; Victor Garcia; Yan Ding; Cheng-Chia Wu; Krutanjali Thakar; John R Falck; Errabelli Ramu; Michal Laniado Schwartzman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

2.  GERV: a statistical method for generative evaluation of regulatory variants for transcription factor binding.

Authors:  Haoyang Zeng; Tatsunori Hashimoto; Daniel D Kang; David K Gifford
Journal:  Bioinformatics       Date:  2015-10-17       Impact factor: 6.937

3.  Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer.

Authors:  Sean P Dineen; Christina L Roland; Rachel Greer; Juliet G Carbon; Jason E Toombs; Puja Gupta; Nabeel Bardeesy; Haizhou Sun; Noelle Williams; John D Minna; Rolf A Brekken
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

Review 4.  Angiogenesis in diabetes and obesity.

Authors:  Rui Cheng; Jian-xing Ma
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

5.  Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis.

Authors:  Dirk Schmidt; Björn Textor; Oliver T Pein; Alexander H Licht; Sven Andrecht; Melanie Sator-Schmitt; Norbert E Fusenig; Peter Angel; Marina Schorpp-Kistner
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

6.  Visualization of AP-1 NF-kappaB ternary complexes in living cells by using a BiFC-based FRET.

Authors:  Y John Shyu; Christopher D Suarez; Chang-Deng Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-02       Impact factor: 11.205

7.  Genetic disruption of Fra-1 decreases susceptibility to endotoxin-induced acute lung injury and mortality in mice.

Authors:  Michelle Vaz; Narsa M Reddy; Subbiah Rajasekaran; Sekhar P Reddy
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

8.  Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos.

Authors:  Benjamin A Krishna; Monica S Humby; William E Miller; Christine M O'Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-15       Impact factor: 11.205

9.  In oesophageal squamous cells exposed to acidic bile salt medium, omeprazole inhibits IL-8 expression through effects on nuclear factor-κB and activator protein-1.

Authors:  Xiaofang Huo; Xi Zhang; Chunhua Yu; Qiuyang Zhang; Edaire Cheng; David H Wang; Thai H Pham; Stuart J Spechler; Rhonda F Souza
Journal:  Gut       Date:  2013-09-18       Impact factor: 23.059

10.  Transcriptional activity of c-Jun is critical for the suppression of AR function.

Authors:  Chih-Chao Hsu; Chang-Deng Hu
Journal:  Mol Cell Endocrinol       Date:  2013-03-21       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.